Does prebiotic soda actually reach your gut?

The added fiber can reach the colon, where gut bacteria can use it. Whether a can also makes a noticeable difference to digestion depends on the type and amount of fiber, how regularly you drink it, and how well you tolerate it. The clearest evidence is that certain fibers, at sufficient doses, increase bifidobacteria. That finding does not establish every benefit covered by the much broader phrase “gut health.”

What makes a soda prebiotic?

Prebiotic sodas are carbonated drinks with added fibers intended to feed particular gut bacteria. Chicory inulin is a common ingredient. The products discussed here contain roughly 2–9 g of total fiber per can, although formulas vary and labels can change. Total fiber is not necessarily the same as the amount of inulin. Some cans provide amounts near the lower end of those tested in human trials of Bifidobacterium, the bacterial genus behind many of the category’s health claims.

Other ingredients include Jerusalem artichoke, cassava root extracts, and fructooligosaccharides, or FOS. Some drinks also contain apple cider vinegar, often abbreviated ACV, which has a different proposed role. Sweeteners may include stevia, monk fruit, or small amounts of cane sugar. Looking at both the ingredient list and the nutrition label is more informative than relying on the word “prebiotic” on the front.

The category gained attention around the late 2010s and early 2020s as interest in functional foods and gut health grew. Prebiotic sodas are sometimes confused with drinks such as kombucha or kefir, which can contain live cultures. Feeding microbes already in the gut and consuming live microbes are different approaches. A drink containing live cultures is not automatically a clinically established probiotic, either. Even the distinction between a prebiotic soda and sparkling water with added fiber is not always meaningful.

The main promises fall into four groups:

• a more diverse gut microbiome;
• easier digestion and more regular bowel movements;
• a smaller blood sugar response with products containing apple cider vinegar;
• a nutritionally better alternative to sugar-sweetened soda.

These are separate claims. A product could be a useful lower-sugar swap without having demonstrated an effect on microbiome diversity or blood glucose.

What is actually in a can?

Start with the fiber source. A blend can contain several ingredients, but the finished drink may not have been studied as a whole. Evidence about an isolated ingredient does not automatically describe the effect of every blend, especially when the amount of each ingredient is undisclosed.

Chicory root inulin

Chicory inulin comes from Cichorium intybus. It is a fructan: a carbohydrate made of linked sugar units, with chain length varying between preparations. It is one of the better-studied prebiotic fibers used in these drinks.

A meta-analysis of 50 studies involving 2,525 participants found that chicory-derived inulin-type fructans increased Bifidobacterium at intakes of 3–20 g per day. Results were clearer in healthy people and some other populations than in participants with gastrointestinal disorders. That distinction matters when a drink is marketed to people who already have digestive symptoms.

A separate paper reported two four-week crossover trials in people with low fiber intake, with 25 participants in each trial and doses of 3 g or 7 g per day. The 7 g result was more consistent across measurement methods. At 3 g, a targeted bacterial test detected an increase, whereas the broader sequencing analysis did not retain a significant result after adjustment for multiple comparisons. A low dose can have an effect, but the study does not establish a universal threshold at which every can works. Nor did those trials show a treatment-related increase in fecal short-chain fatty acids or a difference in gastrointestinal symptoms.

Jerusalem artichoke and cassava root extracts

Jerusalem artichoke contains inulin-type fructans. Cassava root is a source of starch. These are not interchangeable ingredients, and a label saying “root extract” does not by itself explain how the material behaves in the gut.

Processing can change chain length, the resistant fraction of starch, and how rapidly an ingredient is fermented. Those differences can influence both bacterial responses and gas production. The broader inulin literature may help explain Jerusalem artichoke fructans, but it cannot simply be transferred to all cassava extracts. For cassava, the precise composition and processing determine whether the ingredient has relevant prebiotic properties.

FOS, when included

Fructooligosaccharides are shorter-chain fructans that can also support bifidobacteria. A systematic review and meta-analysis of FOS supplementation included eight studies. Bifidobacteria increased overall, with more pronounced effects in the higher-dose range of 7.5–15 g per day and with interventions lasting more than four weeks. The review did not find comparable changes in all the other bacterial groups it examined.

Shorter-chain fructans can ferment more rapidly than longer-chain inulin. That gives a plausible reason for differences in digestive tolerance, although the review did not find an overall significant increase in the gastrointestinal symptoms it pooled. Individual responses and the amount consumed still matter.

Apple cider vinegar, when included

Apple cider vinegar is not a prebiotic fiber. It contains organic acids and is included for a different set of proposed effects. A systematic review and meta-analysis of clinical trials found that vinegar could reduce glucose and insulin responses after a meal.

The amount of vinegar in a soda may be smaller than the amounts tested, and it may not be stated clearly on the label. Without knowing that amount, it is not possible to match the drink to a study dose. Results from a deliberate vinegar intervention cannot simply be assigned to a can that lists vinegar among its ingredients.

How prebiotic fermentation works

Once inulin-type fructans reach the colon, particular bacteria can ferment them. At sufficient doses, they often increase bifidobacteria. This “bifidogenic” effect is the most direct explanation for some of the gut-health messaging. What follows from that change, such as an improvement in the intestinal barrier or less systemic inflammation, requires its own evidence.

A systematic review of nine randomized controlled inulin trials found the most consistent change at 5–20 g per day was an increase in Bifidobacterium. A larger meta-analysis of 50 studies supported that result. The smaller review also identified an important limit: changes in bacterial composition were not consistently accompanied by changes in short-chain fatty acids measured in people.

Bifidobacteria mainly produce acetate and lactate during carbohydrate fermentation. Other members of the gut community can use these products, contributing to the production of compounds such as butyrate and propionate. This exchange is called cross-feeding. Lactate is a fermentation product, but it should not be grouped with the short-chain fatty acids as though the terms were identical.

Short-chain fatty acids, or SCFAs, may help regulate the intestinal barrier, inflammatory processes, and appetite signaling. Fermentation pathways are described in laboratory models of the human colon. Much of the evidence connecting those pathways to effects throughout the body comes from laboratory and animal work. A plausible mechanism is useful context; it does not tell us how much benefit a person will get from a particular drink.

Vinegar works through a different proposed pathway. Acetic acid may slow stomach emptying and influence the glucose response to a meal. A mechanistic review discusses human intervention findings alongside molecular mechanisms. In a controlled study, a reduction in the 60-minute glucose response was apparent with a high-glycemic meal.

That is a meal-specific finding, not a general solution for high blood sugar. It is tempting to assume that a small amount of vinegar produces a smaller version of the same effect. Whether the amount in a particular soda produces any measurable effect needs to be tested rather than inferred.

How strong are the health claims?

A can may supply an amount of fiber near the lower end of studied intakes. The strength of a claim also depends on the outcome: more of a particular bacterial group, less bloating, more regular bowel movements, or a change in blood glucose. These outcomes should not be treated as synonyms.

The descriptions below are an interpretation of the available studies, not a formal evidence-grading exercise for commercial sodas. Most of the research concerns ingredients, not the finished drinks. Dose, study population, duration, and the measured outcome all affect how well a finding applies.

More bifidobacteria is not necessarily more diversity

The evidence that inulin-type fructans increase bifidobacteria at studied doses is reasonably consistent. The 50-study meta-analysis with 2,525 participants examined intakes of 3–20 g per day. Its findings fit with the review of nine inulin trials and a multi-omics study of a prebiotic fiber blend in healthy adults.

But more bifidobacteria does not necessarily mean more types of bacteria overall. Dietary fibers tend to favor particular responsive organisms rather than reliably increase overall microbiome diversity. A selective effect can still be biologically interesting. It simply does not support a broader diversity claim without an actual diversity measurement.

Bowel regularity has some direct evidence

In a randomized controlled trial published in Gut, inulin-type fructans changed specific bacterial groups: Bifidobacterium and Anaerostipes increased, while Bilophila decreased. These changes were associated with softer stools and better constipation-related quality of life. Association between a bacterial change and a symptom change does not establish that one caused the other.

A 2025 randomized, double-blind crossover trial studied 39 adults with functional constipation using 12 g of inulin per day for four weeks. It reported improvements in bowel habits. There was evidence of carryover between treatment periods, so the authors also analyzed the first period separately; that analysis supported a benefit but does not remove the study’s limitations. The intervention was measured inulin supplementation, not a branded soda.

There is therefore a reasonable basis for expecting certain fibers to help bowel regularity in some people when the dose and duration are appropriate. That does not guarantee greater comfort. A rapid increase in fermentable fiber can produce more gas and bloating even when stools become easier to pass.

Blood sugar claims depend on the vinegar dose and population

A systematic review of seven controlled trials in people with type 2 diabetes found lower fasting glucose and HbA1c with apple cider vinegar. It also found a statistically significant increase in insulin, while HOMA-IR, a calculated estimate of insulin resistance, did not change significantly. These mixed findings should not be condensed into a claim that vinegar uniformly improves insulin sensitivity.

A broader systematic review reported modest improvements in some lipid measurements and fasting glucose. The populations, vinegar doses, and study designs matter. Results in people with type 2 diabetes do not establish the same effect in adults with normal glucose regulation.

Nor do these studies establish an effect from the amount of vinegar in a single soda. A small, meal-dependent effect is a hypothesis worth distinguishing from a proven product benefit. People taking medication for diabetes should not change their treatment on the assumption that a drink will reproduce the effects seen in these trials.

A lower-sugar alternative can be useful on its own terms

Less added sugar and some additional fiber can be a meaningful nutritional improvement over a sugar-sweetened soda of the same serving size. This is the most straightforward comparison to make from the label. It does not establish that the drink is better than water alongside a fiber-rich meal.

Any benefit attributed specifically to the fiber still depends on its type, amount, and regular consumption. A single can may not consistently reach the intake tested for a particular outcome. Drinking more cans to chase a study dose also adds cost and may increase gastrointestinal symptoms.

A meta-analysis of 32 randomized controlled trials found reductions in body weight, BMI, fat mass, and waist circumference with chicory inulin-type fructans compared with placebo. The interventions and doses were often different from those in a can of soda. The analysis is evidence about supplementation; it is not evidence that buying a prebiotic soda causes weight loss.

When prebiotic soda can cause bloating

Fermentable fiber can support digestion and cause symptoms at the same time. This is especially relevant for people sensitive to FODMAPs, a group of fermentable carbohydrates that includes fructans.

People with diarrhea-predominant or mixed-type irritable bowel syndrome, known as IBS-D and IBS-M, may react to an abrupt increase in these fibers. Bloating, gas, and abdominal discomfort are common concerns. Symptoms may also worsen in some people with small intestinal bacterial overgrowth, or SIBO. During an active flare of inflammatory bowel disease, or IBD, dietary decisions should follow the gastroenterology care plan. A functional drink is not a substitute for treatment.

An older dose-escalation study in 14 healthy volunteers found excessive gas above 30 g of FOS per day, bloating and bowel sounds above 40 g, and cramps and diarrhea at 50 g. Gradual regular exposure did not improve tolerance in that experiment. These are observations from a small study, not personal safety limits or a promise that lower amounts will cause no symptoms.

A separate tolerance study in 26 healthy adults tested 5 g and 10 g doses in breakfast challenges and monitored symptoms over the following 48 hours. Native inulin at 10 g and oligofructose at 5 g were generally tolerated, while 10 g of oligofructose caused more gastrointestinal symptoms. This was an acute challenge study, not proof that any formulation at those doses will remain comfortable with long-term daily use.

Four or five cans can add up to a substantial amount of fiber, depending on the product, but not every combination reaches the doses in those experiments. Count total intake rather than treating a can as a standardized dose. The type of fiber and the rest of the diet also influence tolerance.

Medication use may matter. It is not possible to give a blanket assurance about interactions for all added fibers or all drink formulations. For regular use of concentrated vinegar, potential concerns include additive glucose-lowering effects with insulin or sulfonylureas and potassium issues in people taking potassium-lowering diuretics. The relevance of these concerns to the small or undisclosed vinegar amounts in sodas has not been established. A medication review should consider the actual product and amount, without assuming either that an interaction is certain or that none is possible.

Before a laboratory test, follow the instructions from the clinic or laboratory. Some glucose-testing protocols allow only water during the fasting period. Preparation differs between tests, including tests used in pregnancy. There is no established universal “vinegar washout” period for soda drinkers. If digestive symptoms are being investigated, regular use of a fiber-containing drink is worth mentioning as part of the diet history.

Different situations call for different decisions:

• With IBS or FODMAP sensitivity, a smaller amount, possibly less than a can, may be easier to assess than a full serving. This is an individual tolerance decision, not a validated dosing schedule or a guarantee that gradual escalation will work.
• During an active IBD flare, follow the gastroenterology team’s dietary advice.
• With SIBO, fermentable ingredients may aggravate symptoms; discuss a planned change with the treating clinician.
• If you use insulin or a sulfonylurea, discuss regular vinegar-containing products in the context of your medication and glucose monitoring.
• Let the clinic determine preparation for fasting glucose or glucose tolerance testing. Do not invent a pause in medications or foods based on a soda’s marketing claims.

The useful question is how the ingredients fit your condition, medications, and tolerance. A general recommendation on social media cannot account for those differences.

What measurements could show a change?

A stool and symptom diary can capture changes in digestion more directly than the vague impression of “better gut health.” Blood tests do not directly answer whether a prebiotic soda is working.

Comparing a baseline, or day 0, with a later day can help organize observations. It does not turn a personal experiment into a controlled trial. A package of hs-CRP, HbA1c, fasting glucose, and stool tracking is not an established routine testing protocol for prebiotic drinks. Tests should follow a clinical question, rather than being ordered simply because a drink makes a health claim.

• hs-CRP is a marker of systemic inflammation. Fermentation and SCFA biology provide a hypothesis about how fiber might influence inflammation. A systematic review of SCFAs, prebiotics, synbiotics, and systemic inflammation explores that relationship. It does not establish a soda-specific program of 8–12 weeks or averaging two or three hs-CRP measurements. Fluctuation in an inflammation marker is not a direct readout of a drink’s effect.
• HbA1c reflects average glucose exposure over approximately three months. Interest in vinegar comes partly from trials in people with type 2 diabetes. Those findings do not justify routine testing before starting a soda and again after 12 weeks. Whether a small amount of vinegar in a drink affects HbA1c is a separate question.
• Fasting glucose can complement HbA1c when there is a medical reason to assess glucose regulation. Follow the laboratory’s preparation instructions rather than arranging a self-directed vinegar pause.
• Fasting insulin and HOMA-IR can be used in some clinical or research settings. They have not been validated as earlier or more sensitive measures of whether a prebiotic soda benefits a person. The vinegar review did not find a significant overall change in HOMA-IR.
• A stool and symptom diary records bowel movement frequency, stool consistency, and the severity of bloating. It addresses the advertised digestive changes most directly and requires no blood draw.

Structured observation is more useful than spending another six months wondering whether anything has changed. Even then, a change in the expected direction does not prove causation. Other food choices, medicines, illness, activity, and ordinary day-to-day variation can affect both symptoms and laboratory values.

Who might find prebiotic soda useful?

The clearest use is as a lower-sugar replacement for a sugar-sweetened soda someone already enjoys. Any additional fiber benefit is a separate consideration. A drink can also make a small contribution when usual fiber intake is low, though it should not become the main strategy for improving the diet.

US fiber reference values are often summarized as 25–38 g per day. More precisely, the National Academies’ Adequate Intake is 25 g per day for women and 38 g for men ages 19–50. These are age- and life-stage-specific reference values, not a universal target for every adult. They are Adequate Intakes, or AIs, rather than Recommended Dietary Allowances, or RDAs. A frequently repeated estimate of about 15 g per day for average US intake is not a current, universally applicable population figure; intake varies with the survey, age, and group studied.

Someone already eating plenty of fiber may have less room for a meaningful improvement than someone with a low intake. There is no established cutoff at 25 g beyond which added fiber becomes nutritionally irrelevant. The particular fiber, total diet, sugar content, and tolerance still matter.

Prebiotic soda is not an established treatment for IBS, IBD, or another diagnosed gastrointestinal condition. Those conditions may require medical evaluation and tailored dietary advice. The drink can be part of a diet without being a treatment for the disease.

Cost is also a practical consideration. One or two cans each day can become a regular expense. Comparing the price with fiber-rich foods can help, but the result depends on local prices and serving sizes. A can may be convenient and enjoyable; that does not establish that it is the cheapest way to obtain the same amount of fiber.

Other ways to support gut health

Fiber-rich foods and, when appropriate, a specific fiber supplement offer other ways to increase intake. Whether they deliver more value than a soda depends on the food or supplement, the amount, and the person’s goal. Vinegar is another ingredient discussed in this context, but evidence about post-meal glucose does not make it a general gut-health treatment.

Beans, lentils, oats, berries, and vegetables supply fiber along with other nutrients and plant compounds. Their fiber content varies widely. A blanket estimate of 5–15 g per serving is not accurate for every food on that list, particularly a small serving of berries or vegetables. The actual food and portion are what matter.

The US 25–38 g reference values need the age and sex context described above. A can can contribute toward total fiber intake without replacing the range of foods that supply it. Different fibers also have different effects; “more fiber” is not a single standardized intervention.

If a supplement is appropriate, psyllium, inulin or FOS powders, and partially hydrolyzed guar gum allow more explicit control over dose than a mixed drink. Evidence for one does not establish the effect of all the others. For inulin specifically, there is a randomized trial in functional constipation and a trial linking inulin-type fructans with softer stools and better constipation-related quality of life. These findings apply to the tested preparations and populations.

For vinegar, a meta-analysis found smaller glucose and insulin responses after meals, with high-glycemic meals particularly relevant to the underlying literature. That does not establish a general treatment recommendation. Whether a small amount in a soda produces a measurable effect remains uncertain. Even a genuine glucose effect would not, by itself, show that vinegar is a cost-effective way to improve gut health.

Know the starting point before judging the result

Has bowel movement frequency changed? Are stools easier to pass? Is bloating better or worse? These concrete questions are easier to track than a general sense that the microbiome must be healthier.

Trying a drink can be a modest experiment in taste and tolerance. It is not a way to establish why a symptom changed. A recorded baseline helps with recall, but it does not replace an appropriate comparison group or a clinical assessment. Blood measurements such as hs-CRP and HbA1c may feel more objective, yet they still cannot isolate the effect of one beverage.

Persistent bloating, suspected IBS, unexplained changes in bowel habits, or unexplained weight loss deserve medical evaluation rather than repeated experiments with functional drinks. A clinician can use the symptom pattern and history to decide which investigations, if any, are appropriate.

What matters when choosing a drink

A lower-sugar prebiotic soda can be a reasonable alternative to a sugar-sweetened soda. That is a useful role without treating it as therapy for a digestive problem.

The roughly 2–9 g of total fiber in the products discussed here may include inulin-type fructans, other fibers, or a mixture. Some also contain apple cider vinegar. Increases in bifidobacteria and certain vinegar-related glucose effects have been described at studied doses. A real-world can’s effect depends on its ingredients and amounts, how often it is consumed, and the person’s starting diet and health.

For digestive changes, a simple diary is usually more relevant than a panel of blood tests. There is no established clinical basis for routinely measuring hs-CRP, HbA1c, and fasting glucose just to evaluate a soda. Taste, tolerance, price, and the food it replaces are practical guides. Fiber-rich foods remain a way to obtain fiber alongside a broader range of nutrients.

Frequently asked questions

Does prebiotic soda actually work?

Some effects are plausible and supported at the ingredient level. Chicory inulin can increase bifidobacteria at studied doses. Whether a can containing roughly 2–9 g of total fiber provides enough of the relevant ingredient, and whether that leads to a noticeable benefit, depends on the formulation and regular intake. The mechanism alone does not establish that every product improves digestion.

How much prebiotic fiber does a can contain?

The products discussed here supply roughly 2–9 g of total fiber per 12-US-fl-oz can, about 355 mL. Check the current label; total fiber may come from several sources and is not necessarily all inulin. Chicory, Jerusalem artichoke, and cassava-derived ingredients can have different properties.

A paper reporting two trials in people with low fiber intake tested 3 g and 7 g of inulin daily. The 7 g result was more consistent; at 3 g, the result depended on the measurement method and statistical adjustment. This supports a dose-sensitive effect, not a guarantee that any product in that range will have the same benefit.

Is prebiotic soda the same as a probiotic?

No. Prebiotic fibers provide substrates for particular microbes already in the gut. Probiotics supply live microorganisms with demonstrated health benefits when used appropriately. These approaches can complement each other, but they are not interchangeable.

There is also no general rule that taking both always works best. The strain, fiber, dose, and outcome would need to be studied together. A background guide to probiotics and colony-forming units explains the terminology; it is not primary evidence for a combined-treatment claim.

Can I drink prebiotic soda every day?

A single can may be comfortable for some people, but daily tolerance depends on the formulation and the rest of the diet. There is no universal one-can rule that establishes safety or benefit across products.

Several cans can add a substantial amount of fermentable fiber. In a small FOS study, gas increased at intakes above 30 g per day. That is not a threshold below which everyone is symptom-free, and the findings cannot be transferred to every blend. With a diagnosed gastrointestinal condition, discuss a regular extra source of fermentable fiber in the context of your care plan.

Who should avoid prebiotic soda?

People with FODMAP sensitivity, SIBO, or IBD, particularly during a flare, may find that fermentable ingredients aggravate symptoms. That does not make every prebiotic soda contraindicated for every person with one of these conditions. Ingredients, amount, disease activity, and individual tolerance should guide the decision.

If you take insulin or a sulfonylurea, discuss regular use of vinegar-containing products with your clinician. The amounts in drinks are variable, and clinically important interactions at ordinary soda servings have not been established. Advice should be based on the actual product, not the assumption that all vinegar-containing drinks behave alike.

What side effects can prebiotic soda cause?

The main concerns are gas, bloating, and abdominal discomfort. These become more likely with large amounts of fermentable fiber, but sensitive people can react at lower intakes. In the small FOS experiment, gas increased above 30 g per day and cramps and diarrhea appeared at 50 g. These observations are not universal dosing limits.

Vinegar can reduce glucose and insulin responses after a meal at studied doses. The relevance of smaller drink amounts is uncertain. People using glucose-lowering medication should consider that uncertainty with their clinician rather than adjusting medication around the drink.

Is prebiotic soda better than regular soda?

It can contain less sugar and fewer calories than a conventional sugar-sweetened soda, while adding some fiber. Compare the actual labels and the same serving size.

The fiber contribution is still only part of a day’s intake. For someone sensitive to fermentable carbohydrates, the extra fiber may also mean more bloating. A favorable label comparison does not guarantee that the drink will feel better to that person.

Which biomarkers should I track?

Drinking a prebiotic soda does not create a routine need for blood tests. hs-CRP reflects systemic inflammation, and HbA1c reflects longer-term glucose exposure, but neither is a validated measure of whether a particular soda benefits you.

A review of SCFA biology and a meta-analysis of apple cider vinegar in type 2 diabetes provide relevant background. They do not justify universal baseline testing or repeat testing after 8–12 weeks for soda drinkers. Medical context should determine testing. A stool and symptom diary is more direct for digestive changes, although it cannot establish causation on its own.

Sources

• Nagy DU, Sándor-Bajusz KA, Bódy B, Decsi T, Van Harsselaar J, Theis S, Lohner S (2023). Effect of chicory-derived inulin-type fructans on abundance of Bifidobacterium and on bowel function: a systematic review with meta-analyses. Critical reviews in food science and nutrition, 63(33), 12018-12035. https://doi.org/10.1080/10408398.2022.2098246

• Dou Y, Yu X, Luo Y, Chen B, Ma D, Zhu J (2022). Effect of Fructooligosaccharides Supplementation on the Gut Microbiota in Human: A Systematic Review and Meta-Analysis. Nutrients, 14(16). https://doi.org/10.3390/nu14163298

• Shishehbor F, Mansoori A, Shirani F (2017). Vinegar consumption can attenuate postprandial glucose and insulin responses; a systematic review and meta-analysis of clinical trials. Diabetes research and clinical practice, 127, 1-9. https://doi.org/10.1016/j.diabres.2017.01.021

• Le Bastard Q, Chapelet G, Javaudin F, Lepelletier D, Batard E, Montassier E (2020). The effects of inulin on gut microbial composition: a systematic review of evidence from human studies. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 39(3), 403-413. https://doi.org/10.1007/s10096-019-03721-w

• Wang LY, He LH, Xu LJ, Li SB (2024). Short-chain fatty acids: bridges between diet, gut microbiota, and health. Journal of gastroenterology and hepatology, 39(9), 1728-1736. https://doi.org/10.1111/jgh.16619

• Ashaolu TJ, Ashaolu JO, Adeyeye SAO (2021). Fermentation of prebiotics by human colonic microbiota in vitro and short-chain fatty acids production: a critical review. Journal of applied microbiology, 130(3), 677-687. https://doi.org/10.1111/jam.14843

• Lim J, Henry CJ, Haldar S (2016). Vinegar as a functional ingredient to improve postprandial glycemic control-human intervention findings and molecular mechanisms. Molecular nutrition & food research, 60(8), 1837-49. https://doi.org/10.1002/mnfr.201600121

• Johnston CS, Buller AJ (2005). Vinegar and peanut products as complementary foods to reduce postprandial glycemia. Journal of the American Dietetic Association, 105(12), 1939-42. https://doi.org/10.1016/j.jada.2005.07.012

• Kang JW, Tang X, Walton CJ, Brown MJ, Brewer RA, Maddela RL, Zheng JJ, Agus JK, Zivkovic AM (2022). Multi-Omic Analyses Reveal Bifidogenic Effect and Metabolomic Shifts in Healthy Human Cohort Supplemented With a Prebiotic Dietary Fiber Blend. Frontiers in nutrition, 9, 908534. https://doi.org/10.3389/fnut.2022.908534

• Cantu-Jungles TM, Hamaker BR (2023). Tuning Expectations to Reality: Don’t Expect Increased Gut Microbiota Diversity with Dietary Fiber. The Journal of nutrition, 153(11), 3156-3163. https://doi.org/10.1016/j.tjnut.2023.09.001

• Vandeputte D, Falony G, Vieira-Silva S, Wang J, Sailer M, Theis S, Verbeke K, Raes J (2017). Prebiotic inulin-type fructans induce specific changes in the human gut microbiota. Gut, 66(11), 1968-1974. https://doi.org/10.1136/gutjnl-2016-313271

• Puhlmann ML, Wegh CAM, van der Zalm SCC, Dam V, Doolan A, Meyer D, Belzer C, Vaughan EE, Benninga MA, Smidt H (2025). Inulin-induced improvements on bowel habit and gut microbiota in adults with functional constipation: findings of a randomized, double-blind, placebo-controlled study. BMC gastroenterology, 25(1), 806. https://doi.org/10.1186/s12876-025-04409-6

• Arjmandfard D, Behzadi M, Sohrabi Z, Mohammadi Sartang M (2025). Effects of apple cider vinegar on glycemic control and insulin sensitivity in patients with type 2 diabetes: A GRADE-assessed systematic review and dose-response meta-analysis of controlled clinical trials. Frontiers in nutrition, 12, 1528383. https://doi.org/10.3389/fnut.2025.1528383

• McLoughlin RF, Berthon BS, Jensen ME, Baines KJ, Wood LG (2017). Short-chain fatty acids, prebiotics, synbiotics, and systemic inflammation: A systematic review and meta-analysis. The American Journal of Clinical Nutrition, 106(3), 930–945. https://doi.org/10.3945/ajcn.117.156265

• Tehrani SD, Keshani M, Rouhani MH, Moallem SA, Bagherniya M, Sahebkar A (2025). The Effects of Apple Cider Vinegar on Cardiometabolic Risk Factors: A Systematic Review and Meta-analysis of Clinical Trials. Current medicinal chemistry, 32(11), 2257-2274. https://doi.org/10.2174/0929867331666230822102021

• Reimer RA, Theis S, Zanzer YC (2024). The effects of chicory inulin-type fructans supplementation on weight management outcomes: systematic review, meta-analysis, and meta-regression of randomized controlled trials. The American journal of clinical nutrition, 120(5), 1245-1258. https://doi.org/10.1016/j.ajcnut.2024.09.019

• Briet F, Achour L, Flourié B, Beaugerie L, Pellier P, Franchisseur C, Bornet F, Rambaud JC (1995). Symptomatic response to varying levels of fructo-oligosaccharides consumed occasionally or regularly. European journal of clinical nutrition, 49(7), 501-7. https://pubmed.ncbi.nlm.nih.gov/7588500/

• Bonnema AL, Kolberg LW, Thomas W, Slavin JL (2010). Gastrointestinal tolerance of chicory inulin products. Journal of the American Dietetic Association, 110(6), 865-8. https://doi.org/10.1016/j.jada.2010.03.025

• Reimer RA, Soto-Vaca A, Nicolucci AC, Mayengbam S, Park H, Madsen KL, Menon R, Vaughan EE (2020). Effect of chicory inulin-type fructan-containing snack bars on the human gut microbiota in low dietary fiber consumers in a randomized crossover trial. The American journal of clinical nutrition, 111(6), 1286-1296. https://doi.org/10.1093/ajcn/nqaa074

• Institute of Medicine. Dietary Reference Intakes: Guiding Principles for Nutrition Labeling and Fortification. Dietary Reference Intakes tables (Total Fiber, Adequate Intakes). https://www.nationalacademies.org/read/10872/chapter/13